Clinical Study

Mortality and Recovery of Renal Function in Acute Kidney Injury Patients Treated with Prolonged Intermittent Hemodialysis Sessions Lasting 10 versus 6 Hours: Results of a Randomized Clinical Trial

Table 7

Univariate logistic regression of clinical and laboratory characteristics and dialysis complications associated with the recovery of renal function in patients with AKI treated with PHD.

ParameterORConfidence Intervalp value

Age1.010.99 – 1.030.17
Gender0.740.37 – 1.500.41
Weight0.990.97 – 1.000.27
Infectious focus
SAH0.660.34 – 1.270.21
DM0.980.48 – 1.970.95
CKD1.90.52 – 7.20.32
ATN-ISS1.170.15 – 9.180.87
SOFA0.920.81 – 1.040.19
Pre FB0.930.78 -1.100.41
Post FB0.830.69 – 0.990.04
Pre Ur1.000.99 – 1.000.71
Post Ur0.990.98 – 1.000.65
Pre Cr0.880.57 – 0.960.03
Post Cr1.000.97- 1.030.57
Pre K0.770.56 – 1.050.10
Post K0.680.34 – 1.380,29
Pre Bic1.070.99 – 1.150.08
Post Bic1.000.85 – 1.180.92
Pre UF1.090.94 – 1.270,24
Post UF0.940.72 – 1.230,67
Hypotension1.80.92 – 3.670,08
Coagulation0.860.44 – 1.690.67
Hypokalemia0.740.33 – 1.670.47
Hypophosphataemia1.100.53 – 2.290.78

OR: odds ratio.
AKI: acute renal injury, PHD: prolonged hemodialysis, SAH: systemic arterial hypertension, DM: diabetes mellitus, CKD: chronic kidney disease, ATN-ISS: acute tubular necrosis individual severity score, SOFA: sequential organ failure assessment score, FB: fluid balance, Ur: urea, Cr: creatinine, K: potassium, Bic: bicarbonate, UF: ultrafiltration, and RF: renal function. Pre = 1st session, post = 3rd session of PHD.